Atea Pharmaceuticals Inc

NASDAQ:AVIR   3:59:56 PM EDT
26.26
-0.87 (-3.21%)
Earnings Announcements

Atea Pharmaceuticals Provides Clinical And Corporate Update, Reports Q2 Results

Published: 08/12/2021 22:00 GMT
Atea Pharmaceuticals Inc (AVIR) - Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Second Quarter 2021 Financial Results.
Atea Pharmaceuticals, Inc. - Qtrly Earnings per Share $0.02.
Revenue is expected to be $53.46 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $103.46 Million
Next Quarter EPS Guidance is expected to be $0.38

More details on our Analysts Page.